✦ LIBER ✦

A randomized trial of 24- vs. 48-week courses of PEG interferon α-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in Taiwan

✍ Scribed by Ming-Lung Yu; Chia-Yen Dai; Zu-Yau Lin; Li-Po Lee; Nei-Jen Hou; Ming-Yen Hsieh; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wen-Yu Chang; Wan-Long Chuang

Book ID: 111237444
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 136 KB
Volume: 26
Category: Article
ISSN: 0106-9543
DOI: 10.1111/j.1478-3231.2005.01196.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized trial of peginterferon α-2a p

Randomized trial of peginterferon α-2a plus ribavirin versus peginterferon α-2b plus ribavirin for chronic hepatitis C in Japanese patients

✍ Shiho Miyase, Katsuki Haraoka, Yoshihiro Ouchida, Yuko Morishita, Shigetoshi Fuj 📂 Article 📅 2012 🏛 Springer Japan 🌐 English ⚖ 227 KB

Comparison of a 6-month course peginterf

Comparison of a 6-month course peginterferon α-2b plus ribavirin and interferon α-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan

✍ S.-D. Lee; M.-L. Yu; P.-N. Cheng; M.-Y. Lai; Y.-C. Chao; S.-J. Hwang; W.-Y. Chan 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Treatment effects and predictors of a 24

Treatment effects and predictors of a 24-week course of interferon α-2b plus ribavirin combination therapy for patients with chronic hepatitis C

✍ Masahiko Tomimatsu; Yoshio Aizawa; Yoshimichi Chuganji; Hideo Ishizuka; Yoshiyuk 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

Dose comparison study of pegylated inter

Dose comparison study of pegylated interferon-α-2b plus ribavirin in naïve Japanese patients with hepatitis C virus genotype 2: A randomized clinical trial

✍ Tomokazu Kawaoka; Yoshiiku Kawakami; Keiji Tsuji; Hiroyuki Ito; Mikiya Kitamoto; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

Peginterferon α-2b plus ribavirin compar

Peginterferon α-2b plus ribavirin compared with interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4

✍ F. Z. Alfaleh; Q. Hadad; M. S. Khuroo; A. Aljumah; A. Algamedi; H. Alashgar; M. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

The results of a randomized trial lookin

The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon α-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1

✍ C. Brandão; A. Barone; F. Carrilho; A. Silva; M. Patelli; C. Caramori; R. Focacc 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB